What Is Jeuveau?
Jeuveau (prabotulinumtoxinA-xvfs) is a botulinum toxin type A that received FDA approval in February 2019. It's the first neurotoxin developed exclusively for aesthetics, with no medical indications cluttering its identity.
Manufactured in South Korea by Daewoong Pharmaceutical and distributed in the US by Evolus, Jeuveau represents a new generation of aesthetic-focused neurotoxins. Same active ingredient as Botox, different company, different positioning.
The product launched with aggressive marketing targeting millennials and younger demographics who might feel intimidated by Botox's medical heritage. Whether that matters to you is personal preference.
Jeuveau Quick Facts
- Generic name: PrabotulinumtoxinA-xvfs
- Brand name: Jeuveau (#NEWTOX)
- Manufacturer: Daewoong (Korea) / Evolus (US)
- FDA approval: February 2019
- Indication: Glabellar lines (frown lines only)
The #NEWTOX Branding: Marketing or Meaningful?
Let's be honest about what #NEWTOX is: a marketing strategy. A very effective one, but marketing nonetheless. Evolus wanted to distinguish Jeuveau from Botox's decades of brand equity, so they created an entirely new identity.
What #NEWTOX Represents
The Marketing Angle
- •Hashtag-friendly for social media
- •Appeals to Instagram/TikTok generation
- •Distance from "your mom's Botox"
- •Creates shareable brand identity
The Product Reality
- •Same mechanism as all neurotoxins
- •Comparable efficacy and safety
- •Similar duration of results
- •Slightly lower price point
Should the branding influence your decision? Probably not. The product works regardless of what you call it. But if the fresh branding makes you more comfortable trying your first neurotoxin, that's a valid psychological benefit.
The Bottom Line on Branding
#NEWTOX is clever marketing, not a fundamentally different product. Choose based on price, availability, and your provider's recommendation. The hashtag won't affect your results.
Aesthetic-Only Focus: Feature or Limitation?
Jeuveau is FDA approved only for cosmetic use. Unlike Botox, which treats chronic migraines, excessive sweating, muscle spasticity, and more, Jeuveau does one thing: smooth frown lines.
Evolus positions this as a feature, not a bug. Their argument: by focusing exclusively on aesthetics, providers who use Jeuveau are aesthetic specialists, not medical practitioners who happen to offer cosmetic services.
Why Aesthetic-Only Might Be Good
- ✓Providers focus purely on aesthetics
- ✓No "medical" stigma for cosmetic seekers
- ✓Simpler product positioning
- ✓Company resources focused on one use
Limitations to Consider
- ×No medical insurance coverage possible
- ×Can't treat migraines or hyperhidrosis
- ×Limited FDA-approved treatment areas
- ×Less overall clinical data
If You Need Medical Treatment
If you suffer from chronic migraines, excessive sweating (hyperhidrosis), or other conditions that Botox treats, Jeuveau isn't an option for those uses. Botox is the only neurotoxin with extensive FDA-approved medical indications.
The Evolus Story
Evolus is the US company that markets Jeuveau. They're not a traditional pharmaceutical giant but rather an aesthetics-focused company that licensed Korean technology to enter the US market.
Company Profile
Founded for Aesthetics
Evolus was created specifically to bring an aesthetic-focused neurotoxin to market. They don't make medical devices or pharmaceutical drugs.
Daewoong Partnership
The product is manufactured by Daewoong Pharmaceutical in Korea, the same company behind Nabota. Evolus handles US distribution and marketing.
Publicly Traded
Evolus (EOLS) is publicly traded on NASDAQ, providing financial transparency. They're a legitimate company with regulatory oversight.
Being smaller than Allergan isn't necessarily bad. Evolus is laser- focused on aesthetics and has strong incentives to ensure Jeuveau succeeds. They're not a pharmaceutical giant, but they're not a fly-by-night operation either.
Cost Comparison: Where Jeuveau Shines
Jeuveau's competitive pricing is one of its strongest selling points. As a challenger brand, Evolus priced it to undercut Botox and gain market share.
Botox Pricing
Jeuveau Pricing
Potential Annual Savings
At 10-20% less per treatment, switching from Botox to Jeuveau could save $200-500 per year depending on your treatment frequency and dosing. Over five years, that's $1,000-2,500. Not life-changing, but meaningful.
Clinical Results: How Does Jeuveau Perform?
Jeuveau's FDA approval was based on two Phase 3 clinical trials (TRANSPARENCY 1 and 2) that demonstrated it works effectively for glabellar lines.
Clinical Trial Highlights
Response Rate
At day 30, approximately 65% of Jeuveau patients achieved a 2-grade improvement in frown line severity, compared to 2% for placebo. This is comparable to Botox's performance.
Duration
Effects lasted approximately 3-4 months, consistent with Botox and other neurotoxins. No advantage or disadvantage in longevity.
Safety
Side effects were similar to other neurotoxins: headache, injection site reactions, and rare eyelid drooping. No unique safety concerns.
Real-world results from providers and patients align with clinical data. Jeuveau works. It's not dramatically better or worse than Botox for its approved indication. The differences between modern neurotoxins are subtle.
For First-Timers: Is Jeuveau a Good Starting Point?
If you've never had neurotoxin treatment before, you might wonder whether to start with the established leader (Botox) or a newer alternative like Jeuveau.
Why Jeuveau Works for Beginners
Lower Entry Cost
The slightly lower price makes trying neurotoxins less of a financial commitment for first-timers.
Same Safety Profile
FDA approval means it meets the same safety standards as Botox. You're not taking on extra risk.
Modern Branding
If the #NEWTOX positioning makes you feel more comfortable, that psychological benefit is real.
Easy to Switch
If you want to try Botox later, the 1:1 unit conversion makes switching straightforward.
First-Timer Advice
For purely cosmetic frown line treatment, Jeuveau is a perfectly reasonable first choice. Start with a conservative dose, see how you like neurotoxin treatment, and adjust from there. You can always try Botox later for comparison.
Switching Between Products
Whether you're considering switching from Botox to Jeuveau or vice versa, the process is straightforward.
How to Switch
Wait for Wear-Off
Let your current treatment wear off completely (3-4 months). This gives you a clean baseline.
Same Units
Tell your provider your previous dosing. Both products use identical unit measurements.
Compare Results
Note onset time, peak effect quality, duration, and any differences in how the product feels.
Decide Based on Experience
After trying both, stick with whichever gives you results you prefer at a price you like.
Many patients try multiple neurotoxins before settling on a favorite. There's no penalty for switching. It's actually a smart way to find what works best for your individual physiology.
Evolus Rewards vs Alle
Both companies offer loyalty programs. If you're a regular neurotoxin user, rewards can add up to meaningful savings.
Alle (Allergan)
- ✓Established program with millions of members
- ✓Works across Allergan portfolio (Botox, Juvederm, etc.)
- ✓Points on every treatment
- ✓Regular promotions and bonus offers
Evolus Rewards
- ✓Newer program, growing membership
- ✓Focused on Jeuveau
- ✓Competitive point earning
- ✓Launch promotions often available
Alle has the advantage of being established and working across multiple products. If you also use Juvederm fillers, combining everything in Alle makes sense. If Jeuveau is your only aesthetic treatment, Evolus Rewards works fine.
Making Your Choice
Here's a simple framework for deciding between Jeuveau and Botox.
Decision Guide
Choose Botox if:
- • You need medical treatment (migraines, hyperhidrosis)
- • You value the longest safety track record
- • You're happy with current Botox results
- • You use other Allergan products (Juvederm, etc.)
- • Brand trust matters to you
Choose Jeuveau if:
- • You only want cosmetic frown line treatment
- • You want to save 10-20% on treatment costs
- • You're new to neurotoxins and price-conscious
- • Your provider recommends or offers promotions
- • You enjoy trying newer products
The Honest Take
For purely aesthetic frown line treatment, Jeuveau and Botox produce similar results. The main practical differences are price (Jeuveau is cheaper) and approved uses (Botox has medical indications). Everything else is marketing.
Frequently Asked Questions
What is Jeuveau?
Jeuveau (prabotulinumtoxinA) is a botulinum toxin type A product FDA approved in 2019 specifically for aesthetic use. Made by Evolus using Korean manufacturing technology from Daewoong Pharmaceutical, it's marketed as #NEWTOX and positioned as a modern alternative to Botox for treating frown lines.
Why is Jeuveau called #NEWTOX?
Evolus branded Jeuveau as #NEWTOX to position it as a fresh, modern alternative to established neurotoxins. The hashtag-friendly name targets millennials and Gen Z who grew up with social media. It's marketing, but it reflects the product's positioning as the 'Instagram generation' neurotoxin.
Is Jeuveau cheaper than Botox?
Often yes. Jeuveau typically costs 10-20% less than Botox per unit, though pricing varies by provider. Evolus positioned Jeuveau competitively to gain market share. Many providers offer promotional pricing, especially for first-time Jeuveau patients.
Does Jeuveau work as well as Botox?
Clinical trials showed Jeuveau is non-inferior to Botox for treating glabellar lines. Most patients and providers report similar efficacy. Both products smooth frown lines effectively when properly dosed by an experienced injector.
How long does Jeuveau last compared to Botox?
Both last approximately the same: 3-4 months for most patients. Neither has a significant duration advantage. Individual results vary based on metabolism, muscle strength, and dosing.
Does Jeuveau use the same units as Botox?
Yes. Jeuveau uses a 1:1 unit conversion with Botox. If you typically get 20 units of Botox for frown lines, you'd get 20 units of Jeuveau. This makes comparing and switching straightforward.
Can Jeuveau treat migraines like Botox?
No. Jeuveau is FDA approved only for cosmetic use (glabellar lines). It has no medical indications. Botox is approved for chronic migraines, hyperhidrosis, muscle spasticity, and other medical conditions. If you need treatment for medical conditions, Botox is the choice.
Is Jeuveau good for first-time neurotoxin users?
Yes, Jeuveau is a legitimate option for first-timers. Its aesthetic-only focus means your provider specializes in cosmetic results. The lower price point also makes it accessible for those wanting to try neurotoxins without the full Botox investment.
Who makes Jeuveau?
Jeuveau is marketed by Evolus, a US aesthetics company. The product is manufactured by Daewoong Pharmaceutical in South Korea using their proprietary process. This is the same manufacturer behind Nabota, a popular Korean neurotoxin.
Does Jeuveau have a rewards program?
Yes. Evolus offers the Evolus Rewards program, which provides points and savings on Jeuveau treatments. While not as established as Allergan's Alle program, it offers competitive benefits for regular patients.
Can I switch from Botox to Jeuveau?
Yes, you can switch between them freely. Wait until your current Botox wears off (3-4 months), then try Jeuveau at your next appointment. The 1:1 unit conversion makes transitioning simple. Many patients try both to compare.
Is Jeuveau FDA approved?
Yes. Jeuveau received FDA approval in February 2019 for moderate to severe glabellar lines (frown lines) in adults. It was the first new neurotoxin approved in the US in nearly a decade at that time.